mRNA

© The DNA Universe/istockphoto/KJN

On the Dark Equus caballus Podcast, Dr. Robert Malone, creator of mRNA vaccine technology, said the COVID vaccine lipid nanoparticles — which tell the body to produce the spike poly peptide — leave the injection site and accrue in organs and tissues.

On June 10, Dr. Robert Malone, creator of mRNA vaccine technology, joined evolutionary biologist Bret Weinstein, Ph.D., for a 3-hour conversation on the Night Horse Podcast to talk over multiple rubber concerns related to the Pfizer and Moderna vaccines.

In this brusk outtake from the full podcast, Malone, Weinstein and tech entrepreneur Steve Kirsch bear upon the implications of the controversial Japanese Pfizer biodistribution report . The written report was fabricated public before this month by Dr. Byram Bridle, a viral immunologist.

They also hash out the lack of proper creature studies for the new mRNA vaccines, and the theory , espoused by virologist Geert Vanden Bossche, Ph.D., that mass vaccination with the mRNA vaccines could produce ever more transmissible and potentially deadly variants.

As The Defender reported June 3, Bridle received a re-create of a Japanese biodistribution study — which had been kept from the public — as a result of a freedom of information request made to the Japanese government for Pfizer data.

Prior to the study's disclosure, the public was led to believe by regulators and vaccine developers that the spike protein produced by mRNA COVID vaccines stayed in the shoulder where it was injected and was not biologically agile — even though regulators around the world had a copy of the study which showed otherwise.

The biodistribution report obtained past Bridle showed lipid nanoparticles from the vaccine did not stay in the deltoid musculus where they were injected every bit the vaccine's developers claimed would happen, only circulated throughout the body and accum ulated in big concentrations in organs and tissues, including the spleen, bone marrow, liver, adrenal glands and — in "quite high concentrations" — in the ovaries.

The mRNA — or messenger RNA — is what tells the trunk to manufacture the fasten protein. The lipid nanoparticles are similar the "boxes" the mRNA is shipped in, according to Malone. "If you observe lipid nanoparticles in an organ or tissue, that tells you the drug got to that location," Malone explained.

According to the data in the Japanese study, lipid nanoparticles were institute in the whole blood circulating throughout the body within 4 hours, and then settled in large concentrations in the ovaries, bone marrow and lymph nodes.

Malone said there needed to be monitoring of vaccine recipients for leukemia and lymphomas as there were concentrations of lipid nanoparticles in the bone marrow and lymph nodes. But those signals often don't show upwardly for six months to ix years downwardly the road, he said.

Usually, signals like this are picked up in animal studies and long-term clinical trials, just this didn't happen with mRNA vaccines, Malone said. There are 2 adverse effect signals that are becoming apparent to the U.S. Food and Drug Administration (FDA). Ane of them is thrombocytopenia — not having enough platelets, which are manufactured in the bone marrow. The other is reactivation of latent viruses.

Malone establish the ovarian signal perplexing because there is no accumulation in the testes.

Malone said the original data packages contained this biodistribution information. "This data has been out there a long fourth dimension" within the protected, non-disclosed, purview of the regulators beyond the world, he said.

According to Malone, the FDA knew the COVID spike protein was biologically active and could travel from the injection site and cause adverse events, and that the spike protein, if biologically active, is very dangerous.

In fact, Malone was i of many scientists to warn the FDA nigh the dangers of the gratis fasten protein.

Malone suggested autoimmune bug may be related to free-circulating fasten protein which developers assured would not happen. To pick upward autoimmune bug, a 2- to iii- year follow-upwards flow in phase three patients would exist required to monitor for potential autoimmune consequences from vaccines — just that monitoring didn't happen with the Pfizer and Moderna vaccines.

Pfizer and Moderna also didn't conduct proper brute studies, Weinstein said. What the beast models requite us is a point that alerts us to what we need to follow up on in humans. Weinstein said:

"Nosotros've got very alarming short-term stuff. We've got short-term stuff that is alarming on the footing of where nosotros detect these lipids, where we detect the fasten proteins — those things are reasons for concern because it wasn't supposed to exist this way. We've also got an alarming signal in terms of the hazards and deaths or the harms and the deaths that are reported in the system and there are reasons to remember they are dramatic nether-reports."

Vaden Bossche got it correct

I of the potential harms from the vaccines, Weinstein said, was fabricated famous by Vanden Bossche, a vaccinologist who worked with GSK Biologicals, Novartis Vaccines, Solvay Biologicals, Pecker & Melinda Gates Foundation's Global Wellness Discovery team in Seattle, and Global Alliance for Vaccines and Immunization in Geneva.

Before this year, Vanden Bossche put out a call to the Globe Health Organisation, supported by a 12-folio document , that described the "uncontrollable monster" that a global mass vaccination campaign could potentially unleash.

Vanden Bossche said a combination of lockdowns, and farthermost pick pressure on the virus induced by the intense global mass vaccination plan, might diminish the number of cases, hospitalizations and deaths in the short-term, but ultimately, will induce the creation of more than mutants of concern. This is what Vanden Bossche calls "immune escape" (i.e. incomplete sterilization of the virus by the human allowed system, fifty-fifty post-obit vaccine assistants).

Immune escape will in turn trigger vaccine companies to further refine vaccines that will add, not reduce, the selection pressure, producing ever more transmissible and potentially deadly variants.

The selection pressure will crusade greater convergence in mutations that bear upon the critical spike protein of the virus that is responsible for breaking through the mucosal surfaces of our airways, the road used by the virus to enter the man body.

The virus will effectively outsmart the highly specific antigen-based vaccines being used and tweaked, depending on the circulating variants. All of this could lead to a hockey stick-like increment in serious and potentially lethal cases — in upshot, an out-of-control pandemic.

Malone said:

"Vanden Bossche's business organization is non theoretical. Information technology is real and we have the data. We're stuck with this virus or its downstream variants pretty much for the rest of our lives and it'southward going to become more than like the flu. We volition accept continuing evolution and circulation of variants, and that is an escape."